Arbutus Biopharma, X-Chem And Proteros Announce Arbutus Has 'identified several molecules that inhibit the SARS-CoV-2 nsp5 main protease'; Arbutues Achieves Worldwide Exclusive License To Identified Molecules

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!